{
    "symbol": "HOLX",
    "quarter": 3,
    "year": 2022,
    "date": "2022-07-27 23:23:04",
    "content": " One, these businesses have strong underlying growth; and two, the true growth rate is somewhere in between last quarter's results and this quarter's, underscoring the need to view how our strength evolves over time, and given the variability of COVID, that no single quarter result is going to match a linear model. Our third quarter financial performance highlights the strength of our core Diagnostics and Surgical businesses, both of which surpassed our long-term revenue target of 5% to 7% growth in the period."
}